Call to arrange a consultation
+1 416 777 0888

Lundbeck Canada Inc. v. Sandoz Canada Inc.

2024
T-971-22
Pending
6(1) PMNOC

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,655,212 and 2,705,163 (vortioxetine).

Counsel to: 
Sandoz Canada Inc.
here.

Meet the team

Arrow down